Megan Colligan) - 07 Mar 2023 Form 4 Insider Report for IMAX CORP (IMAX)

Signature
/s/ Kenneth I. Weissman (attorney-in-fact for Megan Colligan)
Issuer symbol
IMAX
Transactions as of
07 Mar 2023
Net transactions value
-$860,091
Form type
4
Filing time
09 Mar 2023, 15:55:53 UTC
Previous filing
05 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMAX common shares Options Exercise $0 +25,270 +33% $0.000000 102,577 07 Mar 2023 Direct F1
transaction IMAX common shares Options Exercise $0 +7,732 +7.5% $0.000000 110,309 07 Mar 2023 Direct F1
transaction IMAX common shares Options Exercise $0 +15,241 +14% $0.000000 125,550 07 Mar 2023 Direct F1
transaction IMAX common shares Options Exercise $0 +14,019 +11% $0.000000 139,569 07 Mar 2023 Direct F1
transaction IMAX common shares Tax liability $603,177 -32,728 -23% $18.43 106,841 07 Mar 2023 Direct F2
transaction IMAX common shares Award $0 +26,533 +25% $0.000000 133,374 07 Mar 2023 Direct F3
transaction IMAX common shares Tax liability $256,914 -13,940 -10% $18.43 119,434 07 Mar 2023 Direct F4
holding IMAX common shares (opening balance) 77,307 07 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMAX restricted share units Options Exercise $0 -25,270 -100% $0.000000* 0 07 Mar 2023 common shares 25,270 $0.000000 Direct F1, F5, F6, F7, F12
transaction IMAX restricted share units Options Exercise $0 -7,732 -100% $0.000000* 0 07 Mar 2023 common shares 7,732 $0.000000 Direct F1, F5, F6, F8, F12
transaction IMAX restricted share units Options Exercise $0 -15,241 -50% $0.000000 15,241 07 Mar 2023 common shares 15,241 $0.000000 Direct F1, F5, F6, F9, F12
transaction IMAX restricted share units Options Exercise $0 -14,019 -33% $0.000000 28,039 07 Mar 2023 common shares 14,019 $0.000000 Direct F1, F5, F6, F10, F12
transaction IMAX restricted share units Award $0 +40,214 $0.000000 40,214 07 Mar 2023 common shares 40,214 $0.000000 Direct F5, F6, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted share units into common shares.
F2 Ms. Colligan is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
F3 Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2020. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
F4 Ms. Colligan is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.
F5 Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
F6 Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
F7 The restricted share units vest and will be converted to common shares in three installments: 25,269 on each of March 7, 2021 and March 7, 2022 and 25,270 on March 7, 2023.
F8 The restricted share units vest and will be converted to common shares in two equal installments on each of the first two anniversaries of the grant date.
F9 The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.
F10 The restricted share units vest and will be converted to common shares in three installments: 14,019 on each of March 7, 2023 and March 7, 2024 and 14,020 on March 7, 2025.
F11 The restricted share units vest and will be converted to common shares in three installments: 13,404 on each of March 7, 2024 and March 7, 2025 and 13,406 on March 7, 2026.
F12 This represents the number of restricted share units for this transaction only. Ms. Colligan's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 124,573, 83,494 and 119,434, respectively.